U
QURE
Uniqure
21.84
-0.75-3.32%After Hours: 21.63 -0.21 -0.96%18:18 10/12 EDT
OPEN/PREV CLOSE22.38/22.59
TODAY RANGE21.49-22.59
VOL1.41M
MARKET CAP1.51B
52 WEEK RANGE8.73-71.50
AVG VOL (3M)1.97M
% TURNOVER1.78%
TURNOVER--
P/E (TTM)-5.3958
% RANGE4.88%
EPS(TTM)-4.0476
P/E(FORWARD)-5.8067
P/B4.673
BVPS4.674
DIVIDEND--
P/S84.59
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.45B
SHARES OUTSTANDING69.37M
NEXT EARNINGS11/09-11/15
FREE FLOAT66.52M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·4d ago
Is uniQure (QURE) Undervalued On New Huntingtons Data And FDA Filing Clarity?
Seeking Alpha·5d ago
Cedar Grove Capital Q3 2026 Portfolio Update
Simply Wall St·5d ago
Gene Therapy Data Could Be A Big Moment For uniQure Stock (QURE)
Dow Jones·10/05 13:17
uniQure Price Target Cut to $28.00/Share From $60.00 by Barclays
Dow Jones·10/05 13:17
uniQure Cut to Equal-Weight From Overweight by Barclays
Benzinga·10/05 13:06
Barclays Downgrades uniQure to Equal-Weight, Lowers Price Target to $28
TipRanks·10/05 11:35
uniQure downgraded to Equal Weight from Overweight at Barclays
Dow Jones·10/02 13:51
uniQure Price Target Cut to $48.00/Share From $65.00 by RBC Capital
Dow Jones·10/02 13:51
uniQure Is Maintained at Outperform by RBC Capital
Benzinga·10/02 13:41
RBC Capital Maintains Outperform on uniQure, Lowers Price Target to $48
TipRanks·10/02 11:55
uniQure price target lowered to $48 from $65 at RBC Capital
Seeking Alpha·10/01 15:08
ClearPoint Neuro: My Speculative Buy Didn't Pan Out, Moving To Hold
Simply Wall St·10/01 03:23
uniQure (QURE) Reports New AMT 130 Data As FDA Opens Accelerated Review Path
Seeking Alpha·09/30 17:17
uniQure: A Speculative Buy After Huntington's Disease Trial's 4-Year Data Update
Dow Jones·09/30 15:59
uniQure Price Target Cut to $31.00/Share From $46.00 by Goldman Sachs
Same Industry
Name/Symbol
Change%
Price